scholarly journals Adherence and out‐of‐pocket costs among Medicare beneficiaries who are prescribed oral targeted therapies for advanced prostate cancer

Cancer ◽  
2020 ◽  
Vol 126 (23) ◽  
pp. 5050-5059
Author(s):  
Megan E. V. Caram ◽  
Mary K. Oerline ◽  
Stacie Dusetzina ◽  
Lindsey A. Herrel ◽  
Parth K. Modi ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Targeted Therapies ◽  
Advanced Prostate Cancer ◽  
Medicare Beneficiaries ◽  
Out Of Pocket Costs

scholarly journals A Retrospective Observational Analysis of Overall Survival with Sipuleucel-T in Medicare Beneficiaries Treated for Advanced Prostate Cancer

2020 ◽  
Vol 37 (12) ◽  
pp. 4910-4929
Author(s):  
Rana R. McKay ◽  
Jason M. Hafron ◽  
Christine Ferro ◽  
Helen M. Wilfehrt ◽  
Kate Fitch ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Overall Survival ◽  
Advanced Prostate Cancer ◽  
Medicare Beneficiaries ◽  
Observational Analysis

scholarly journals AKR1C3 Promotes AR-V7 Protein Stabilization and Confers Resistance to AR-Targeted Therapies in Advanced Prostate Cancer

2019 ◽  
Vol 18 (10) ◽  
pp. 1875-1886 ◽  
Author(s):  
Chengfei Liu ◽  
Joy C. Yang ◽  
Cameron M. Armstrong ◽  
Wei Lou ◽  
Liangren Liu ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Targeted Therapies ◽  
Advanced Prostate Cancer ◽  
Protein Stabilization

Chromatin relaxation is a feature of advanced prostate cancer

2016 ◽  
Author(s):  
Alfonso Urbanucci ◽  
Stefan Barfeld ◽  
Ville Kytola ◽  
Daniel Vodak ◽  
Liisa Sjoblom ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Advanced Prostate Cancer ◽  
Chromatin Relaxation
Sign in / Sign up

Export Citation Format

Share Document